Compare Heron Therapeutics Inc (HRTX) vs Cloudflare Inc (NET) Price & Performance

HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.

Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.

Cloudflare (NET) trades at $275.19, down 0.87% on the day, as the stock consolidates near recent highs. The company continues to demonstrate strong revenue growth with Q1 2026 earnings beating expectations, though it remains unprofitable with a -3.72% net margin. Technical indicators show a bullish trend with the stock trading above key support levels, while analyst sentiment remains positive with 72.5% recommending Buy. Recent product launches including Precursor behavioral defense highlight ongoing innovation in cybersecurity.

Outlook remains cautiously optimistic as Cloudflare leverages AI-driven cybersecurity demand, though profitability concerns and high valuations (P/S 41.75) present risks. The stock trades below consensus price target of $265.07, suggesting potential upside if execution continues. Key risks include intense competition and the company's ability to achieve sustainable profitability amid significant infrastructure investments.